SARS-CoV-2-induced remission of Hodgkin lymphoma.

Challenor, Sarah; Tucker, David

Challenor, Sarah; Tucker, David.

Challenor S; Department of Haematology, Royal Cornwall Hospital, Truro, UK.
Tucker D; Department of Haematology, Royal Cornwall Hospital, Truro, UK.

Br J Haematol ; 192(3): 415, 2021 02.

Article in English | MEDLINE | ID: covidwho-1003945

Subject(s)

COVID-19/complications; COVID-19/diagnosis; Hodgkin Disease/complications; Hodgkin Disease/diagnosis; SARS-CoV-2; COVID-19/immunology; COVID-19/therapy; Clinical Decision-Making; Disease Management; Hodgkin Disease/drug therapy; Hodgkin Disease/immunology; Humans; Male; Middle Aged; Patient Outcome Assessment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hodgkin Disease / SARS-CoV-2 / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Br J Haematol Year: 2021 Document Type: Article Affiliation country: Bjh.17116

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google